Mason Street Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-100,972
| Closed | -$10M | – | 1543 |
|
|
2019
Q3 | $10M | Buy |
100,972
+390
| +0.4% | +$37.1K | 0.21% | 85 |
|
|
2019
Q2 | $9.3M | Buy |
100,582
+382
| +0.4% | +$36.3K | 0.19% | 91 |
|
|
2019
Q1 | $9.45M | Buy |
100,200
+1,616
| +2% | +$141K | 0.19% | 95 |
|
|
2018
Q4 | $6.32M | Sell |
98,584
-294
| -0.3% | -$21.7K | 0.15% | 114 |
|
|
2018
Q3 | $8.85M | Sell |
98,878
-293
| -0.3% | -$25.9K | 0.18% | 95 |
|
|
2018
Q2 | $7.88M | Sell |
99,171
-5,606
| -5% | -$465K | 0.17% | 100 |
|
|
2018
Q1 | $9.35M | Sell |
104,777
-4,890
| -4% | -$469K | 0.21% | 84 |
|
|
2017
Q4 | $11.4M | Buy |
109,667
+1,062
| +1% | +$120K | 0.26% | 70 |
|
|
2017
Q3 | $15.8M | Buy |
108,605
+235
| +0.2% | +$32K | 0.38% | 48 |
|
|
2017
Q2 | $14.1M | Buy |
108,370
+861
| +0.8% | +$105K | 0.35% | 46 |
|
|
2017
Q1 | $13.4M | Buy |
107,509
+1,465
| +1% | +$175K | 0.34% | 47 |
|
|
2016
Q4 | $12.3M | Buy |
106,044
+1,187
| +1% | +$132K | 0.33% | 52 |
|
|
2016
Q3 | $11M | Buy |
104,857
+523
| +0.5% | +$56.6K | 0.31% | 55 |
|
|
2016
Q2 | $10.3M | Buy |
104,334
+215
| +0.2% | +$22.2K | 0.3% | 60 |
|
|
2016
Q1 | $10.4M | Buy |
104,119
+1,482
| +1% | +$153K | 0.32% | 57 |
|
|
2015
Q4 | $12.3M | Buy |
102,637
+352
| +0.3% | +$40.7K | 0.38% | 48 |
|
|
2015
Q3 | $11.1M | Buy |
102,285
+156
| +0.2% | +$19.4K | 0.37% | 51 |
|
|
2015
Q2 | $11.8M | Sell |
102,129
-975
| -0.9% | -$111K | 0.36% | 53 |
|
|
2015
Q1 | $11.9M | Sell |
103,104
-483,250
| -82% | -$57.7M | 0.36% | 58 |
|
|
2014
Q4 | $65.6M | Buy |
586,354
+49,052
| +9% | +$5.17M | 0.46% | 22 |
|
|
2014
Q3 | $50.9M | Buy |
537,302
+143,453
| +36% | +$12.9M | 0.4% | 33 |
|
|
2014
Q2 | $33.8M | Sell |
393,849
-3,373
| -0.8% | -$257K | 0.26% | 68 |
|
|
2014
Q1 | $27.7M | Sell |
397,222
-303,478
| -43% | -$24M | 0.22% | 96 |
|
|
2013
Q4 | $59.2M | Buy |
700,700
+382,786
| +120% | +$30.3M | 0.48% | 24 |
|
|
2013
Q3 | $24.5M | Sell |
317,914
-51,736
| -14% | -$3.63M | 0.28% | 78 |
|
|
2013
Q2 | $21.6M | Buy |
+369,650
| New | +$22.2M | 0.24% | 105 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Mason Street Advisors's CELG Position: Q4 2019 in Review
Mason Street Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 100,972 shares — an estimated $10M sold.
Mason Street Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $65.6M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Mason Street Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Mason Street Advisors sold 100,972 Celgene Corp shares in Q4 2019, an estimated $10M.
- Mason Street Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Mason Street Advisors's Celgene Corp position peaked at $65.6M in Q4 2014.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Mason Street Advisors's 13F filing for Q4 2019, filed 19 Feb 2020.